Kakali De - Infectious Diseases

Author Information

Kakali De is a researcher associated with the Infectious Diseases and Immunology Division at the Nuclear Medicine Laboratory, part of the CSIR-Indian Institute of Chemical Biology located in Kolkata, West Bengal, India. Her work is primarily focused on targeted drug delivery systems, radiolabeled peptides, and novel approaches in tumor imaging, contributing significantly to the field of cancer treatment and diagnostics.

Research Contributions

Kakali De has made substantial contributions to the field of targeted drug delivery and radiopharmaceuticals, particularly in the context of cancer research. Her work includes the development of modified nanoparticles for drug delivery, the synthesis of radiolabeled peptides for tumor imaging, and the exploration of imaging agents for receptor-positive tumors. Her research has been pivotal in advancing scintigraphic detection techniques and enhancing the effectiveness of anti-cancer therapies.

Aliases

Kakali De is also known by the aliases "K De" and "Kakali De" in academic and research circles.

Publication and Citation Metrics

Metric	Value
Total Papers	43
Total Citations	662
H-index	12

Publications:

Decapeptide Modified Doxorubicin Loaded Solid Lipid Nanoparticles as Targeted Drug Delivery System against Prostate Cancer.

DOI: 10.1021/acs.langmuir.1c01370

Year: 2021

HYNIC and DOMA conjugated radiolabeled bombesin analogs as receptor-targeted probes for scintigraphic detection of breast tumor

DOI: 10.1186/s13550-019-0493-x

Year: 2019

Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor

DOI: 10.1016/j.peptides.2017.01.002

Year: 2017

Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.

DOI: 10.1016/j.actbio.2016.04.026

Year: 2016

Effect Of Surface Modification In Conventional Liposome With Lipophilic Agents

DOI:

Year: 2016

Metabolic stability and biological evaluation of 99mTc-HYNIC-Tyr3-Octreotide as somatostatin receptor positive tumor imaging agent

DOI: 10.1007/s10967-014-3867-6

Year: 2015

Radiolabeled new somatostatin analogs conjugated to DOMA chelator used as targeted tumor imaging agent: synthesis and radiobiological evaluation

DOI: 10.1007/s00726-015-1942-0

Year: 2015

Synthesis, characterization, biodistribution and scintigraphy of 99mTc-paclitaxel: a potential tracer of paclitaxel

DOI: 10.1007/s10967-014-3825-3

Year: 2014

An easy and effective method for radiolabelling of solid lipid nanoparticles

DOI: 10.1007/s10967-014-3258-z

Year: 2014

Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.

DOI: 10.1016/j.ijbiomac.2014.01.049

Year: 2014

Are there specific populations at higher risk for drug interactions?

How is the Warburg Effect Related to Infectious Diseases?

What are Some Natural Alternatives to Chemical Insect Repellents?

What is Chlamydia?

Can COVID-19 be Eradicated?

What is Gene Therapy?

What Are the Considerations for Treating Parasitic Infections?

What are Anopheles Mosquitoes?

What is the Public Health Impact of Salmonella?

How Does the FDA Ensure the Safety of Antiviral Drugs?

Partnered Content Networks

Relevant Topics